FindTrial
Sign In

Impact of CD4 T cell counts and T cell aging on COVID vaccine efficacy among people living with HIV (PLHIV)

Impact of CD4+T cell counts and T cell senescence on COVID vaccine efficacy among people living with HIV (PLHIV) - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041881
Enrollment
250
Registered
2022-04-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B973- Retrovirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HIV Negative control group: Age above 18 years, negative by HIV Screening test. PLHIV: Age above 18 years, CD4 T cell counts and HIV viral loads Willing to participate with written Informed consent and willing informed consent and willing to provide samples at the stipulated time intervals

Exclusion criteria

Exclusion criteria: Participants who withdraw or are lost to follow up after the first sample.

Design outcomes

Primary

MeasureTime frame
The Impact of CD4 Tcell counts and T cell senescence/exhaustion on the COVID vaccine efficacy among PLHIVTimepoint: 6 months, 12 months and 24 months—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDrKPriya

VHS IDMC

vhsclinresearch@gmail.com09962081313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026